Van Gogh for Lung Cancer Biopsy

About CellTivity Scientific

CellTivity Scientific, founded in 2015 and based in Lyon, France, with significant US operations, is a commercial-stage diagnostics company in the cell therapy and regenerative medicine sectors. Its core technology, the Van Gogh™ Dynamic Cell Imaging platform, visualizes cellular metabolic activity in real-time to guide proceduralists during biopsies, with the goal of improving diagnostic yield and sample adequacy for next-generation sequencing. The company is targeting the lung cancer diagnosis market first, with endorsements from US-based interventional pulmonologists, and appears to be generating early revenue from the commercial rollout of its Van Gogh system.

Therapeutic Areas